SUVEN
Suven Life Sciences Limited
Each stock's 10,000-path forecast, rendered as light.
Suven Life Sciences Limited (SUVEN) Stock Analysis & Case Study
Is SUVEN a good buy? The data-driven verdict.
Suven Life Sciences Limited (SUVEN) trades at ₹318,on the numbers it tread carefully, a Downstox Snapshot Score of 41/100.
On the numbers, Suven Life Sciences Limited (SUVEN) tread carefully, a Downstox Snapshot Score of 41/100, weighing fairly valued at 22.4× earnings, ROE of -81.5%, a 47% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
SUVEN fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How SUVEN ranks against the 2,373 companies in our screener
- SUVEN's market cap of 8,997 Cr ranks in the 74th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SUVEN's book value of ₹22 ranks in the 20th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SUVEN's promoter holding of 65.5% ranks in the 64th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SUVEN's 3-year profit (PAT) growth of 68.0% ranks in the 89th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SUVEN's 3-year revenue growth of -19.0% ranks in the bottom 5% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SUVEN's debt-to-equity ratio of 0.03x is lower than 90% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is SUVEN overvalued? SUVEN P/E vs peers
SUVEN trades at 22.4× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
SUVEN share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of SUVEN history (36%/yr drift, 58%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| SUVEN 2027 | ₹142 | ₹302 | ₹638 | -5% |
| SUVEN 2028 | ₹99 | ₹286 | ₹825 | -10% |
| SUVEN 2029 | ₹75 | ₹271 | ₹978 | -15% |
| SUVEN 2030 | ₹57 | ₹256 | ₹1,156 | -19% |
| SUVEN 2031 | ₹45 | ₹243 | ₹1,303 | -24% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability SUVEN goes up, or doubles?
The bull case for SUVEN
- SUVEN's P/E of 22.4x is lower than 58% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹978.
The bear case & risks
- A steep 14.2× price-to-book means most of the value is intangible/expectations, not assets on the books.
- SUVEN's Piotroski F-Score of 2/8 ranks in the 6th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- High historical volatility (58%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹75.
SUVEN volatility & expected range, how bumpy is the ride?
Over the last 9.8 years SUVEN compounded at 36%/year with annualized volatility of 58%. That volatility implies a 1-year 80% range of ₹142-₹638, the honest backbone behind any single price target.
SUVEN price forecast, the full 60-month probability fan
SUVEN price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds SUVEN hits common targets within the simulated horizon?
Full multi-horizon detail on the SUVEN price target & forecast page.
SUVEN Piotroski F-Score: 2/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. SUVEN scores 2/8, weak on the financial-strength checks.
SUVEN MTF margin & leverage across 6 brokers
Margin Trading Facility lets you buy SUVEN with part of the capital. Lower margin % = higher leverage. Rates compared across 6 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| ZerodhaCHEAPEST | 42.55% | 2.4× |
| Groww | 42.72% | 2.3× |
| Kotak Neo | 100.00% | 1.0× |
| Paytm Money | 100.00% | 1.0× |
| Pocketful | 42.58% | 2.3× |
| Share India | 42.65% | 2.3× |
Compare every broker on the SUVEN MTF page.
About Suven Life Sciences Limited: sector, index & market-cap context
Suven Life Sciences Limited (SUVEN) is a small-cap NSE-listed company, with a market capitalisation of ₹8,997 Cr. See more stocks on our screener.
How the SUVEN Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Suven Life Sciences Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
SUVEN analysis, FAQs
Is Suven Life Sciences Limited (SUVEN) a good buy?
On the numbers, Suven Life Sciences Limited (SUVEN) tread carefully, a Downstox Snapshot Score of 41/100, weighing fairly valued at 22.4× earnings, ROE of -81.5%, a 47% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is SUVEN overvalued or undervalued?
SUVEN trades at 22.4× earnings, fairly valued versus the ~22× long-run Nifty average.
What is the SUVEN share price target for 2031?
SUVEN's probability-weighted 2031 median target is ₹243, with an 80% range of ₹45-₹1,303 (10,000-path Monte-Carlo).
What is the probability SUVEN doubles in 5 years?
The modelled probability of SUVEN reaching ₹637 (2×) within 5 years is 23%.
What is the bull case for SUVEN?
SUVEN's P/E of 22.4x is lower than 58% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in SUVEN?
A steep 14.2× price-to-book means most of the value is intangible/expectations, not assets on the books. SUVEN's Piotroski F-Score of 2/8 ranks in the 6th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026. High historical volatility (58%/yr) means a wide, bumpy range of outcomes, size positions accordingly.